Root Cause Investigation of Unusual Results Experienced during Master Cell Bank (MCB) Testing and Characterization

References

1. 1.↵
   1. Chen D.,
   2. Nims R.,
   3. Dusing S.,
   4. Miller P.,
   5. Luo W.,
   6. Quertinmont M.,
   7. Parekh B.,
   8. Poorbaugh J.,
   9. Boose J. A.,
   10. Atkinson E. M.

   Root cause investigation of a viral contamination incident occurred during master cell bank (MCB) testing and characterization—a case study. Biologicals 2008, 36 (6), 393–402.

   OpenUrlCrossRefPubMed
2. 2.↵
   Points to consider in the characterization of cell lines used to produce biologicals. Center for Biologics Evaluation and Research, Food and Drug Administration, U.S. Department of Health and Human Services, 1993.
3. 3.↵
   Points to consider in the manufacture and testing of monoclonal antibody production for human use. Center for Biologics Evaluation and Research, Food and Drug Administration, U.S. Department of Health and Human Services, 1997.
4. 4.↵
   Viral safety evaluation of biotechnology products derived from cell lines of human or animal origin. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Q5A, 1998.
5. 5.↵
   Derivation and characterization of cell substrates used for production of biotechnological/biological products. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Q5D, 1997.